MARKET

FBIO

FBIO

Fortress Biotech Inc
NASDAQ
2.760
-0.120
-4.17%
After Hours: 2.787 +0.027 +0.98% 18:11 03/27 EDT
OPEN
2.890
PREV CLOSE
2.880
HIGH
2.890
LOW
2.710
VOLUME
356.89K
TURNOVER
--
52 WEEK HIGH
4.530
52 WEEK LOW
1.325
MARKET CAP
85.66M
P/E (TTM)
-9.4198
1D
5D
1M
3M
1Y
5Y
1D
*Journey Medical FY25 Loss/Shr 47c >DERM
Dow Jones · 4d ago
Fortress Biotech-founded Journey Medical FY2025 revenue rises to $62 million; Emrosi net revenue grows to $15 million
Reuters · 4d ago
*Journey Medical FY25 Rev $61.9M >DERM
Dow Jones · 4d ago
Press Release: Journey Medical Corporation -2-
Dow Jones · 4d ago
Press Release: Journey Medical Corporation -3-
Dow Jones · 4d ago
Press Release: Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights
Dow Jones · 4d ago
After-Hours Earnings Report for March 25, 2026 : JEF, CELC, FUL, EPAC, WS, MLKN, PGEN, BYND, MDV, DERM, FBIO, GCTS
NASDAQ · 4d ago
Weekly Report: what happened at FBIO last week (0316-0320)?
Weekly Report · 6d ago
More
About FBIO
Fortress Biotech, Inc. is a biopharmaceutical company focused on acquiring and advancing assets. The Company has eight marketed prescription pharmaceutical products and over 20 programs in development, with its majority-owned and majority-controlled partners and subsidiaries and partners and subsidiaries it founded and in which it holds significant minority ownership positions. Its portfolio is being commercialized and developed for various therapeutic areas, including oncology, dermatology, and rare diseases. Its dermatology products include Emrosi, Qbrexza, Amzeeq, Zilxi, Exelderm, Targadox, and Luxamend. Its late-stage product candidates include CUTX-101 (copper histidinate injection for Menkes disease), Triplex (cytomegalovirus (CMV) vaccine), and CAEL-101 (monoclonal antibody for AL amyloidosis). Its early and mid-stage product candidates include Dotinurad (urate transporter (URAT1) inhibitor for gout), MB-101 (IL13Rα2 CAR T Cell Program for Glioblastoma), and others.

Webull offers Fortress Biotech Inc stock information, including NASDAQ: FBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FBIO stock methods without spending real money on the virtual paper trading platform.